In this study we concentrated on the value of serological IGFBP2 to identify different tumor characteristics in NSCLC patients and the reversal effect of trichostatin A (TSA) on chemoresistance induced by high IGFBP2 expression. The gene discussed is IGFBP2; the disease is neoplasm.